Hospira Vinorelbine Tartrate10 mg/1 mL Injection Vial

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

vinorelbine tartrate, Quantity: 13.85 mg/mL (Equivalent: vinorelbine, Qty 10 mg/mL)

Disponibil de la:

Hospira Australia Pty Ltd

INN (nume internaţional):

Vinorelbine tartrate

Forma farmaceutică:

Injection

Compoziție:

Excipient Ingredients: water for injections

Calea de administrare:

Intravenous

Unități în pachet:

1 x 1 mL vial

Clasă:

Medicine Listed (Export Only)

Tip de prescriptie medicala:

Not scheduled. Not considered by committee

Indicații terapeutice:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In stage III NSCLC, Vinorelbine is indicated with in combination with cisplatin.

Rezumat produs:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Statutul autorizaţiei:

Listed (Export Only)

Data de autorizare:

2008-05-05